117 related articles for article (PubMed ID: 38215552)
1. Intracellularly delivered human lactoferrin functions as an activator of Na
Kurimoto D; Hue Anh TD; Kasama R; Sato A
Biochem Biophys Res Commun; 2024 Feb; 695():149480. PubMed ID: 38215552
[TBL] [Abstract][Full Text] [Related]
2. A membrane-proximal region in the C-terminal tail of NHE7 is required for its distribution in the trans-Golgi network, distinct from NHE6 localization at endosomes.
Fukura N; Ohgaki R; Matsushita M; Nakamura N; Mitsui K; Kanazawa H
J Membr Biol; 2010 Apr; 234(3):149-58. PubMed ID: 20364249
[TBL] [Abstract][Full Text] [Related]
3. Enhanced intracellular uptake of an albumin fusion protein in cancer cells by its forced cell surface recruitment.
Kurimoto D; Sato A
Eur J Pharm Sci; 2023 Dec; 191():106591. PubMed ID: 37742986
[TBL] [Abstract][Full Text] [Related]
4. Albumin fusion at the N-terminus or C-terminus of human lactoferrin leads to improved pharmacokinetics and anti-proliferative effects on cancer cell lines.
Ueda K; Shimizu M; Ohashi A; Murata D; Suzuki T; Kobayashi N; Baba J; Takeuchi T; Shiga Y; Nakamura M; Kagaya S; Sato A
Eur J Pharm Sci; 2020 Dec; 155():105551. PubMed ID: 32946958
[TBL] [Abstract][Full Text] [Related]
5. Albumin fusion with human lactoferrin shows enhanced inhibition of cancer cell migration.
Nopia H; Kurimoto D; Sato A
Biometals; 2023 Jun; 36(3):629-638. PubMed ID: 36167912
[TBL] [Abstract][Full Text] [Related]
6. Caveolins bind to (Na+, K+)/H+ exchanger NHE7 by a novel binding module.
Lin PJ; Williams WP; Kobiljski J; Numata M
Cell Signal; 2007 May; 19(5):978-88. PubMed ID: 17207967
[TBL] [Abstract][Full Text] [Related]
7. The intracellular Na(+)/H(+) exchanger NHE7 effects a Na(+)-coupled, but not K(+)-coupled proton-loading mechanism in endocytosis.
Milosavljevic N; Monet M; Léna I; Brau F; Lacas-Gervais S; Feliciangeli S; Counillon L; Poët M
Cell Rep; 2014 May; 7(3):689-96. PubMed ID: 24767989
[TBL] [Abstract][Full Text] [Related]
8. Four Na+/H+ exchanger isoforms are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation.
Nakamura N; Tanaka S; Teko Y; Mitsui K; Kanazawa H
J Biol Chem; 2005 Jan; 280(2):1561-72. PubMed ID: 15522866
[TBL] [Abstract][Full Text] [Related]
9. NHE7 upregulation potentiates the uptake of small extracellular vesicles by enhancing maturation of macropinosomes in hepatocellular carcinoma.
Yao Y; Xu Y; Yu L; Xue TM; Xiao ZJ; Tin PC; Fung HL; Ma HT; Yun JP; Yam JWP
Cancer Commun (Lond); 2024 Feb; 44(2):251-272. PubMed ID: 38152992
[TBL] [Abstract][Full Text] [Related]
10. Efficient Endocytosis of the Human Lactoferrin N-Lobe Enhances Its Antiproliferative Activity against Human Cancer Cells.
Nakamura M; Shiga A; Iimori A; Matsuzaki T
Biol Pharm Bull; 2023 Jul; 46(7):1004-1009. PubMed ID: 37088555
[TBL] [Abstract][Full Text] [Related]
11. Golgi Acidification by NHE7 Regulates Cytosolic pH Homeostasis in Pancreatic Cancer Cells.
Galenkamp KMO; Sosicka P; Jung M; Recouvreux MV; Zhang Y; Moldenhauer MR; Brandi G; Freeze HH; Commisso C
Cancer Discov; 2020 Jun; 10(6):822-835. PubMed ID: 32200349
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and characterization of a novel (Na+,K+)/H+ exchanger localized to the trans-Golgi network.
Numata M; Orlowski J
J Biol Chem; 2001 May; 276(20):17387-94. PubMed ID: 11279194
[TBL] [Abstract][Full Text] [Related]
13. Secretory carrier membrane proteins interact and regulate trafficking of the organellar (Na+,K+)/H+ exchanger NHE7.
Lin PJ; Williams WP; Luu Y; Molday RS; Orlowski J; Numata M
J Cell Sci; 2005 May; 118(Pt 9):1885-97. PubMed ID: 15840657
[TBL] [Abstract][Full Text] [Related]
14. Organellar (Na+, K+)/H+ exchanger NHE7 regulates cell adhesion, invasion and anchorage-independent growth of breast cancer MDA-MB-231 cells.
Onishi I; Lin PJ; Numata Y; Austin P; Cipollone J; Roberge M; Roskelley CD; Numata M
Oncol Rep; 2012 Feb; 27(2):311-7. PubMed ID: 22076128
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Na+/H+ exchanger (NHE) 7 by 5-(N-ethyl-N-isopropyl)-Amiloride displays anti-cancer activity in non-small cell lung cancer by disrupting cancer stem cell activity and downregulating PD-L1 expression.
Wang BY; Shen HT; Lee YL; Chien PJ; Chang WW
Am J Cancer Res; 2023; 13(10):4721-4733. PubMed ID: 37970357
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Proliferative Effect of Human Lactoferrin and Its Proteolytic Peptide on Normal and Transformed Epithelial Cells.
Hwang SM; Chung IY; Jo JH; Yoon TJ; Lee HH
Appl Biochem Biotechnol; 2016 Jan; 178(1):44-57. PubMed ID: 26400493
[TBL] [Abstract][Full Text] [Related]
17. Identification and biochemical characterization of the SLC9A7 interactome.
Kagami T; Chen S; Memar P; Choi M; Foster LJ; Numata M
Mol Membr Biol; 2008 Aug; 25(5):436-47. PubMed ID: 18654930
[TBL] [Abstract][Full Text] [Related]
18. Expression and characterization of recombinant human lactoferrin in edible alga Chlamydomonas reinhardtii.
Pang X; Tong Y; Xue W; Yang YF; Chen X; Liu J; Chen D
Biosci Biotechnol Biochem; 2019 May; 83(5):851-859. PubMed ID: 30669954
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo effect of human lactoferrin on glioblastoma growth.
Arcella A; Oliva MA; Staffieri S; Aalberti S; Grillea G; Madonna M; Bartolo M; Pavone L; Giangaspero F; Cantore G; Frati A
J Neurosurg; 2015 Oct; 123(4):1026-35. PubMed ID: 26186026
[TBL] [Abstract][Full Text] [Related]
20. Hinge-Deficient IgG1 Fc Fusion: Application to Human Lactoferrin.
Shiga Y; Murata D; Sugimoto A; Oshima Y; Tada M; Ishii-Watabe A; Imai K; Tomii K; Takeuchi T; Kagaya S; Sato A
Mol Pharm; 2017 Sep; 14(9):3025-3035. PubMed ID: 28763236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
